Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.

The effect of a single dose of paracetamol (1 g) on plasma concentrations of the oral contraceptive steroids ethinyloestradiol (EE2) and levonorgestrel (LNG) has been studied in six healthy female volunteers. The area under the plasma concentration-time curve (AUC0-24) of EE2 was significantly increased following paracetamol administration by 22% (control 2221 +/- 291; following paracetamol, 2702 +/- 452 pg ml-1 h; mean +/- s.d.; P less than or equal to 0.05). The greatest effect was evident in the time period 0-3 h. There was a significant decrease in the AUC of EE2-sulphate after paracetamol (7736 +/- 3791 pg ml-1 h) compared with control (13161 +/- 4535 pg ml-1 h; P less than or equal to 0.05). Plasma concentrations of LNG were unaltered by concurrent paracetamol administration. We conclude that the administration of a single 1 g dose of paracetamol causes an increase in plasma concentrations of EE2 as a result of a reduction in the sulphation of the steroid. This interaction may be of clinical significance in women on oral contraceptive steroids who regularly take paracetamol.

[1]  D. Back,et al.  Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers. , 1987, British journal of clinical pharmacology.

[2]  J. Clements,et al.  The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. , 1984, British journal of clinical pharmacology.

[3]  M. Morris,et al.  Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate , 1983, Clinical pharmacology and therapeutics.

[4]  A. Breckenridge,et al.  The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans. , 1982, British journal of clinical pharmacology.

[5]  J. Lin,et al.  Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion. , 1982, Drug metabolism reviews.

[6]  G Levy,et al.  Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. , 1981, The Journal of pharmacology and experimental therapeutics.

[7]  A. Breckenridge,et al.  Interaction of ethinyloestradiol with ascorbic acid in man. , 1981, British medical journal.

[8]  A. Breckenridge,et al.  The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette. , 1981, Contraception.

[9]  L F Prescott,et al.  Kinetics and metabolism of paracetamol and phenacetin. , 1980, British journal of clinical pharmacology.

[10]  A. Breckenridge,et al.  An investigation of the pharmacokinetics of ethynylestsadiol in women using badioimmunoassay , 1979 .

[11]  A. Breckenridge,et al.  An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay. , 1979, Contraception.

[12]  G. Levy,et al.  Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid. , 1971, Journal of pharmaceutical sciences.

[13]  C. Regårdh,et al.  Drug biotransformation interactions in man. V. Acetaminophen and salicylic acid. , 1971, Journal of pharmaceutical sciences.

[14]  H. Yamada,et al.  Research ArticlesDrug Biotransformation Interactions in Man III: Acetaminophen and Salicylamide , 1971 .

[15]  G. Levy,et al.  Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. , 1971, Journal of pharmaceutical sciences.

[16]  G. Levy,et al.  Pharmacokinetics of salicylamide elimination in man. , 1967, The Journal of pharmacology and experimental therapeutics.